Latest Period
Q1 2026
Security Snapshot
PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) Institutional Ownership
CUSIP: 71742Q106
13F Institutional Holders and Ownership History from Q2 2014 to Q1 2026
Institutions Reporting
256
Shares (Excl. Options)
20,342,513
Price
$55.31
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, par value $0.0001 per share
- Symbol
- PAHC on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 20,342,513
- Total 13F value
- $1,123,312,492
- Portfolio coverage rank
- 0%
- Share change
- +1,024,660
- Value change
- +$63,683,888
- Number of holders
- 256
- Shares outstanding
- 40,564,701
- SEC-reported price per share
- $43.16
- Insider filing price
- $43.16
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PAHC - PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share is tracked under CUSIP 71742Q106.
- 256 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 227 to 256 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $722,326,211 to $1,123,312,492.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 256 institutions filings for Q1 2026.
Security key
71742Q106
Latest holder period
Q1 2026
13F holders
256
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
PAHC full holder history
PHIBRO ANIMAL HEALTH CORP SEC filings
PHIBRO ANIMAL HEALTH CORP company facts
PHIBRO ANIMAL HEALTH CORP insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 71742Q106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
PAHC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BFI Co., LLC | 48% | -2.2% | $1,081,431,408 | -$24,781,535 | 19,552,186 | -2.2% | BFI Co., LLC | 20 May 2026 |
| BlackRock, Inc. | 16% | $57,576,134 | 3,195,124 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | $57,733,795 | 1,043,822 | Vanguard Capital Management | 31 Mar 2026 | |||
| PZENA INVESTMENT MANAGEMENT LLC | 3.6% | -51% | $13,043,417 | -$13,280,199 | 723,830 | -50% | PZENA INVESTMENT MANAGEMENT LLC | 31 Mar 2025 |
| BRANDES INVESTMENT PARTNERS, LP | 3.3% | $11,942,719 | 662,748 | Brandes Investment Partners, L.P. | 31 Dec 2024 | |||
| BARCLAYS PLC | 1.3% | -77% | $14,584,970 | -$43,097,165 | 263,695 | -75% | Barclays PLC | 31 Mar 2026 |
As of 31 Mar 2026, 256 institutional investors reported holding 20,342,513 shares of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC). This represents 50% of the company’s total 40,564,701 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
36%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8% | 3,253,848 | -2.7% | 0% | $179,970,333 |
| FMR LLC | 5.4% | 2,173,126 | +216% | 0.01% | $120,195,611 |
| STATE STREET CORP | 2.3% | 950,033 | +0.82% | 0% | $52,546,325 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2% | 891,283 | 0% | 0% | $49,296,863 |
| ACADIAN ASSET MANAGEMENT LLC | 1.5% | 617,072 | -12% | 0.05% | $34,121,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 604,648 | +6.2% | 0% | $33,449,465 |
| RENAISSANCE TECHNOLOGIES LLC | 1.4% | 576,735 | +5.8% | 0.05% | $31,899,213 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 507,852 | +3.2% | 0.01% | $28,086,214 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2% | 490,342 | 0% | 0% | $27,120,816 |
| Nuveen, LLC | 1.1% | 455,891 | +2.6% | 0.01% | $25,215,331 |
| LORD, ABBETT & CO. LLC | 0.98% | 397,714 | +182% | 0.07% | $21,998,000 |
| MORGAN STANLEY | 0.96% | 391,186 | -13% | 0% | $21,636,561 |
| Invesco Ltd. | 0.82% | 330,977 | +28% | 0% | $18,306,338 |
| Dana Investment Advisors, Inc. | 0.71% | 287,724 | -12% | 0.47% | $15,914,014 |
| Allspring Global Investments Holdings, LLC | 0.71% | 286,172 | +146% | 0.03% | $15,670,779 |
| Ranger Investment Management, L.P. | 0.69% | 278,475 | -0.34% | 1.1% | $15,402,452 |
| OBERWEIS ASSET MANAGEMENT INC/ | 0.68% | 277,100 | +32% | 0.45% | $15,326,401 |
| Capricorn Fund Managers Ltd | 0.66% | 267,045 | +45% | 2.3% | $14,770,259 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.65% | 264,262 | -1.6% | 0% | $14,616,331 |
| Bank of New York Mellon Corp | 0.57% | 229,991 | -0.94% | 0% | $12,720,778 |
| NORTHERN TRUST CORP | 0.54% | 219,401 | +2.9% | 0% | $12,135,069 |
| GLOBEFLEX CAPITAL L P | 0.52% | 210,039 | -2.4% | 1.8% | $11,617,257 |
| Qube Research & Technologies Ltd | 0.51% | 208,449 | -29% | 0.02% | $11,529,314 |
| Russell Investments Group, Ltd. | 0.48% | 193,436 | +7.7% | 0.01% | $10,698,942 |
| CRAWFORD INVESTMENT COUNSEL INC | 0.46% | 187,506 | -5.5% | 0.18% | $10,370,957 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
48
Latest
Q1 2026
Rows shown
1-25 of 48
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 20,342,513 | $1,123,312,492 | +$63,683,888 | $55.31 | 256 |
| 2025 Q4 | 19,327,676 | $722,326,211 | -$11,276,690 | $37.36 | 227 |
| 2025 Q3 | 19,599,542 | $792,990,493 | -$23,250,468 | $40.46 | 216 |
| 2025 Q2 | 20,349,724 | $519,721,694 | +$4,932,349 | $25.54 | 192 |
| 2025 Q1 | 20,230,331 | $431,882,531 | -$6,976,163 | $21.36 | 181 |
| 2024 Q4 | 20,760,076 | $435,958,146 | +$5,855,068 | $21.00 | 171 |
| 2024 Q3 | 20,262,212 | $456,562,597 | +$4,978,935 | $22.52 | 145 |
| 2024 Q2 | 20,104,261 | $337,332,099 | -$3,613,178 | $16.77 | 138 |
| 2024 Q1 | 20,390,841 | $263,815,154 | +$4,780,079 | $12.93 | 137 |
| 2023 Q4 | 20,498,053 | $237,357,830 | +$2,393,108 | $11.58 | 134 |
| 2023 Q3 | 20,056,787 | $257,066,743 | +$637,840 | $12.77 | 124 |
| 2023 Q2 | 19,973,690 | $273,662,577 | -$4,846,655 | $13.70 | 127 |
| 2023 Q1 | 20,301,393 | $311,012,290 | +$5,422,420 | $15.32 | 132 |
| 2022 Q4 | 19,989,777 | $268,089,718 | +$1,271,732 | $13.41 | 129 |
| 2022 Q3 | 19,929,636 | $264,908,464 | -$16,816,591 | $13.29 | 138 |
| 2022 Q2 | 20,667,086 | $395,381,581 | +$3,633,408 | $19.13 | 139 |
| 2022 Q1 | 20,531,472 | $408,823,760 | +$4,262,047 | $19.95 | 143 |
| 2021 Q4 | 20,288,359 | $413,858,025 | -$6,010,185 | $20.42 | 133 |
| 2021 Q3 | 20,413,494 | $439,740,209 | -$19,573,080 | $21.54 | 130 |
| 2021 Q2 | 21,302,215 | $615,117,148 | +$14,536,483 | $28.88 | 142 |
| 2021 Q1 | 21,042,222 | $513,508,005 | +$22,206,837 | $24.40 | 137 |
| 2020 Q4 | 20,306,618 | $394,390,866 | -$4,768,468 | $19.42 | 129 |
| 2020 Q3 | 20,646,036 | $359,251,334 | -$10,719,506 | $17.40 | 131 |
| 2020 Q2 | 44,667,289 | $1,140,259,090 | +$598,684,081 | $26.27 | 148 |
| 2020 Q1 | 20,463,242 | $494,535,691 | -$12,127,558 | $24.17 | 148 |